4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-007331
CEO and CFO bought 10,800 shares at $11.16 ($120,528)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-02-16 | Purchase | +10,800 | $11.16 | $120,528 | 5,336,177 | D |
| Open-market purchases · 10,800 sh · avg $11.16 · $120,528 | |||||||
Loading xslF345X05/ownership.xml…